Phenylacetyl-carnitine

There is 1 paper on phenylacetyl-carnitine in aging research: none in people yet, 1 in animals. The newest story, Nov 9, 2026: “Alzheimer’s mouse models show altered metabolism across organs”.

Biomarker

1 paper studies it1 finding

See all 1 papers on phenylacetyl-carnitine

“we trace phenylacetyl-carnitine in human plasma and serum samples (n = 1,470) from independent cohorts, revealing associations with aging, cognitive impairment, and diminished memory performance.”
A multi-organ metabolomics atlas reveals molecular dysregulations in Alzheimer's disease mouse modelsCell reports2026doi:10.1016/j.celrep.2026.117499
  • Animals1

Associations

1

Cognitive impairment

mixedin humans1

1 study
  1. Phenylacetyl-carnitine is associated with cognitive impairment in humans.

    “we trace phenylacetyl-carnitine in human plasma and serum samples (n = 1,470) from independent cohorts, revealing associations with aging, cognitive impairment, and diminished memory performance.”

    Humansn = 1,470

    Alzheimer’s mouse models show altered metabolism across organs

    Cell reports

More on Cognitive impairment

Latest

Dec 2025: 0Jan 2026: 0Feb 2026: 0Mar 2026: 0Apr 2026: 0May 2026: 0Jun 2026: 1Jul 2026: 0Aug 2026: 0Sep 2026: 0Oct 2026: 0Nov 2026: 01 paper in 12 months
Cell Reports

Alzheimer’s mouse models show altered metabolism across organs

An atlas spanning two mouse models studied with and without microbes found altered bile acids, B vitamins and other molecules across tissues.An atlas spanning two mouse models studied with and without microbes found altered bile acids, B vitamins and other molecules across tissues.

Mouse studyAI & data